Skip to content
akaturk Academic measurement

Article detail · 2025

Neuroprotective potential of carvacrol: restoration of oxidative balance and mitigation of brain injury markers in isoproterenol-induced rats

Journal

Metabolic Brain Disease

ISSN 1573-7365

YÖKSİS OpenAlex Open access · hybrid SJR Q2 JCR Q2 Citations 5 Percentile 85.0% FWCI 1.8
Year
2025
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue Metabolic Brain Disease
  • Catalog match (ISSN) Metabolic Brain Disease
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

This research investigated the protective properties of Carvacrol (CVC) against Isoproterenol (ISO)-induced oxidative stress, neuroinflammation, and mitochondrial dysfunction in rats. The findings showed that CVC treatment did not significantly modify baseline oxidative stress levels in healthy rats but successfully alleviated ISO-induced oxidative damage by augmenting antioxidant enzyme activity and diminishing lipid peroxidation, as demonstrated by a reduction in MDA levels. These findings indicate that CVC can reinstate antioxidant capability and reduce oxidative damage. Concerning neuroinflammation, ISO therapy markedly increased the expression of pro-inflammatory markers, including TNF-α, IL-1β, c-Fos, BDNF, Nfl, and GFP, signifying a robust inflammatory and damage response. The injection of CVC following ISO exposure markedly decreased the expression of these markers, suggesting that CVC may exert a neuroprotective effect by regulating the inflammatory response and mitigating neuronal and glial damage. CVC demonstrated a notable protective effect on mitochondrial integrity, evidenced by the decreased mRNA expression of mitochondrial damage markers, including NSE, s100B, CALP1, and CALM1 in the CVC-treated groups, showing that CVC mitigates mitochondrial dysfunction. The analysis revealed no significant alterations in the expression levels of Aβ40, pTau181, and tTau across all groups, indicating that these biomarkers were not substantially influenced by CVC treatment under the study's conditions. However, β-amyloid accumulation varied significantly between groups, highlighting the need for further research to explore CVC's potential implications in amyloid-related diseases. These findings endorse CVC's neuroprotective efficacy and therapeutic potential in neurological disorders associated with oxidative stress, inflammation, and mitochondrial impairment.

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms
  • Medicinal Plants and Neuroprotection
  • Essential Oils and Antimicrobial Activity

Primary topic Neuroinflammation and Neurodegeneration Mechanisms

Authors

  1. BETÜL BAĞCI
  2. ŞEYMA AYDIN ATATÜRK ÜNİVERSİTESİ
  3. ELİF DALKILINÇ
  4. SELİM ÇOMAKLI ATATÜRK ÜNİVERSİTESİ
  5. SEFA KÜÇÜKLER ATATÜRK ÜNİVERSİTESİ
  6. SELÇUK ÖZDEMİR UŞAK ÜNİVERSİTESİ